In line with this phenomenon, the NAT molecular profile is reported to show the prognostic significance for recurrence in patients with different cancers including CRC [2,3,4], HCC [5], prostate [6], oral carcinoma [7], breast cancer [8] and head and neck cancer [9]. Here, BRD2 is linked to hepatocellular carcinoma.